[1]任雨欣.煤工尘肺合并COPD患者长期规则使用舒利迭的效果[J].医学信息,2020,33(04):147-148.[doi:10.3969/j.issn.1006-1959.2020.04.047]
　REN Yu-xin.Effect of Long-term Regular Use of Seretide in Patients with Coal Worker Pneumoconiosis and COPD[J].Medical Information,2020,33(04):147-148.[doi:10.3969/j.issn.1006-1959.2020.04.047]
点击复制

煤工尘肺合并COPD患者长期规则使用舒利迭的效果()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年04期
页码:
147-148
栏目:
药物与临床
出版日期:
2020-02-15

文章信息/Info

Title:
Effect of Long-term Regular Use of Seretide in Patients with Coal Worker Pneumoconiosis and COPD
文章编号:
1006-1959（2020）04-0147-02
作者:
任雨欣
（国家卫生健康委职业安全卫生研究中心呼吸科，北京 102300）
Author(s):
REN Yu-xin
(Department of Respiratory Medicine,Occupational Safety and Health Research Center,National Health Council,Beijing 102300,China)
关键词:
煤工尘肺; COPD; 舒利迭
Keywords:
Coal worker pneumoconiosis; COPD; Long-term; Seretide
分类号:
R966
DOI:
10.3969/j.issn.1006-1959.2020.04.047
文献标志码:
A
摘要:
目的 分析长期规则运用舒利迭对煤工尘肺合并慢性阻塞性肺疾病（COPD）患者的临床疗效。方法 选取2018年3月~2019年3月在本院收治的煤工尘肺合并COPD患者120例为研究对象，采用随机抽样法将其分成对照组和研究组，各60例。对照组采用沙丁胺醇吸入治疗，研究组在对照组的基础上给予舒利迭治疗。比较两组炎症因子水平以及凝血功能。结果 治疗后研究组血清IL-1水平为（123.51±8.57）ρ/μg·L－1，高于对照组的（89.49±8.62）ρ/μg·L－1，而IFN为（125.11±8.37），低于对照组的（186.36±12.54），差异具有统计学意义（P＜0.05）；研究组D-二聚体、Fib、PLT分别为（0.47±0.28）mg/L、（3.78±0.42）g/L、（345.51±62.27）×109/L，低于对照组的（0.86±0.35）mg/L 、（4.58±0.63）g/L、（415.45±53.28）×109/L，差异具有统计学意义（P＜0.05）。结论 采用舒利迭治疗煤工尘肺合并COPD疗效满意，有助于改善患者的凝血功能，降低血D-二聚体 、Fib及PLT，提高其血清IL-1水平，值得应用。
Abstract:
Objective To analyze the clinical efficacy of long-term regular application of Seretide in patients with coal worker pneumoconiosis with chronic obstructive pulmonary disease (COPD).Methods A total of 120 patients with coal workers’ pneumoconiosis and COPD who were treated in our hospital from March 2018 to March 2019 were selected as the research subjects. They were randomly divided into a control group and a research group, each with 60 patients. The control group was treated with salbutamol inhalation, and the study group was given Seretide therapy on the basis of the control group. The levels of inflammatory factors and coagulation function were compared between the two groups.Results After treatment, the serum IL-1 level in the study group was (123.51±8.57) ρ/μg·L-1, which was higher than that of the control group (89.49±8.62) ρ/μg·L-1, and the IFN was (125.11±8.37),(186.36±12.54) lower than the control group, the difference was statistically significant (P<0.05); D-dimer, Fib, and PLT in the study group were (0.47±0.28)mg/L, (3.78±0.42 )g/L, (345.51±62.27)×109/L, (0.86±0.35)mg/L, (4.58±0.63)g/L, (415.45±53.28)×109/L lower than the control group,the difference was statistically significant(P<0.05).Conclusion The use of Seretide in the treatment of coal worker pneumoconiosis with COPD is satisfactory, which helps to improve the patient’s coagulation function, reduce blood D-dimer, Fib and PLT, and increase its serum IL-1 level, which is worthy of application.

参考文献/References:

[1]郑文旭,张凤革,张晓静,等.加用舒利迭对哮喘合并COPD患者FEV、PEF水平及T淋巴细胞分化的影响分析[J].湖南师范大学学报(医学版),2019,16(1):50-53. [2]刘春涛,冯玉麟.慢性阻塞性肺疾病全球创议慢性阻塞性肺疾病诊断、管理和预防袖珍指南(2006年修订版)[J].中国呼吸与危重监护杂志,2007,6(3):230-237. [3]顾国强,邓泽林,梁锦.布地奈德雾化吸入联合舒利迭治疗慢性阻塞性肺疾病(COPD)合并感染患者临床效果[J].现代诊断与治疗,2017,69(10):82-83. [4]赵丽格,闫佳强,李富东,等.COPD稳定期患者以噻托溴铵联合舒利迭治疗的效果分析[J].国际医药卫生导报,2018,24(12):1849-1851. [5]马玮华.布地奈德雾化吸入联合舒利迭对COPD合并感染患者的临床影响分析[J].系统医学,2017,2(18):39-40. [6]孙成勇.舒利迭对煤工尘肺合并慢性阻塞性肺疾病患者肺功能的影响[J].临床肺科杂志,2017,16(2):309.

相似文献/References:

[1]马建娟.布地奈德联合异丙托溴铵雾化治疗COPD 急性加重期的效果评价[J].医学信息,2018,31(07):141.[doi:10.3969/j.issn.1006-1959.2018.07.048]
　MA Jian-juan.Efficacy Evaluation of Budesonide Combined with Ipratropium Bromide in Treatment of Acute Exacerbation of COPD[J].Medical Information,2018,31(04):141.[doi:10.3969/j.issn.1006-1959.2018.07.048]
[2]任庆玲.聚焦解决模式对慢阻肺患者主要照顾者的 照顾负担及负性情绪影响的研究[J].医学信息,2018,31(07):162.[doi:10.3969/j.issn.1006-1959.2018.07.057]
　REN Qing-ling.Study on the Effect of Focus-resolving Model on the Burden of Care and Negative Emotions of Primary Caregivers in Patients with Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(04):162.[doi:10.3969/j.issn.1006-1959.2018.07.057]
[3]刘 颖,杨志高,李慧琼,等.肠内联合肠外营养与肠内营养支持治疗COPD机械通气患者疗效比较的Meta分析[J].医学信息,2022,35(10):98.[doi:10.3969/j.issn.1006-1959.2022.10.024]
　LIU Ying,YANG Zhi-gao,LI Hui-qiong,et al.Meta-analysis of the Efficacy of Enteral Combined Parenteral Nutrition and Enteral Nutrition Support in the Treatment of COPD Patients with Mechanical Ventilation[J].Medical Information,2022,35(04):98.[doi:10.3969/j.issn.1006-1959.2022.10.024]
[4]刘怡彤,马利军.基于“互联网+”的移动医疗技术在慢性阻塞性肺病稳定期管理的应用及问题研究[J].医学信息,2019,32(06):38.[doi:10.3969/j.issn.1006-1959.2019.06.014]
　LIU Yi-tong,MA Li-jun.Application and Problem Research of Mobile Medical Technology Based on"Internet +"in Stable Period Management of Chronic Obstructive Pulmonary Disease[J].Medical Information,2019,32(04):38.[doi:10.3969/j.issn.1006-1959.2019.06.014]
[5]林 杨,苏志强,鲍 靖,等.ICF核心分类联合mMRC用于COPD患者康复效果的研究[J].医学信息,2019,32(03):175.[doi:10.3969/j.issn.1006-1959.2019.03.060]
　LIN Yang,SU Zhi-qiang,BAO Jing,et al.Effect of ICF Core Classification Combined with mMRC on Rehabilitation of COPD Patients[J].Medical Information,2019,32(04):175.[doi:10.3969/j.issn.1006-1959.2019.03.060]
[6]梁雪梅,蔡晓玉,王 真,等.综合护理措施对无创呼吸机治疗COPD合并呼吸衰竭的Meta分析[J].医学信息,2019,32(05):91.[doi:10.3969/j.issn.1006-1959.2019.05.027]
　LIANG Xue-mei,CAI Xiao-yu,WANG Zhen,et al.Meta-analysis of Comprehensive Nursing Measures for Non-invasive Ventilator in the Treatment of COPD with Respiratory Failure[J].Medical Information,2019,32(04):91.[doi:10.3969/j.issn.1006-1959.2019.05.027]
[7]吴 鹏,徐 超,曲 红.线性周期化训练和非线性周期化训练对慢性阻塞性肺疾病患者的影响[J].医学信息,2019,32(09):88.[doi:10.3969/j.issn.1006-1959.2019.09.028]
　WU Peng,XU Chao,QU Hong.Effects of Linear Periodic Training and Nonlinear Periodic Training on Patients with Chronic Obstructive Pulmonary Disease[J].Medical Information,2019,32(04):88.[doi:10.3969/j.issn.1006-1959.2019.09.028]
[8]马宏境,刘 彬.慢性阻塞性肺疾病发病机制的研究[J].医学信息,2019,32(10):50.[doi:10.3969/j.issn.1006-1959.2019.10.018]
　MA Hong-jing,LIU Bin.Study on the Pathogenesis of Chronic Obstructive Pulmonary Disease[J].Medical Information,2019,32(04):50.[doi:10.3969/j.issn.1006-1959.2019.10.018]
[9]高小燕,陈 蓉,卢慧宇.血糖控制水平对COPD伴2型糖尿病患者 肺功能及其预后的影响[J].医学信息,2019,32(16):76.[doi:10.3969/j.issn.1006-1959.2019.16.023]
　GAO Xiao-yan,CHEN Rong,LU Hui-yu.Effect of Blood Glucose Control Level on Pulmonary Function and Prognosis in Patients with COPD and Type 2 Diabetes[J].Medical Information,2019,32(04):76.[doi:10.3969/j.issn.1006-1959.2019.16.023]
[10]聂 志.吸入用沙丁胺醇联合布地奈德对COPD急性加重期的作用[J].医学信息,2019,32(22):105.[doi:10.3969/j.issn.1006-1959.2019.22.033]
　NIE Zhi.Effect of Inhaled Salbutamol Combined with Budesonide on Acute Exacerbation of COPD[J].Medical Information,2019,32(04):105.[doi:10.3969/j.issn.1006-1959.2019.22.033]

更新日期/Last Update: 2020-02-15